Company intelligence / Profile preview

NeuEsse

Pittsburgh, Pennsylvania, United Statesneuesse.com ↗

Ownership: Private
Development stage: Other

Overview

NeuEsse’s flagship product OmegaSkin™, a plant-based human skin substitute made from soy protein, has demonstrated the ability to heal full-thickness wounds with minimal to no scarring while restoring hair follicles and sweat glands. The product is designed to be off-the-shelf, requiring no special storage or handling. Preclinical studies show promising results in wound healing efficacy. Regulatory risk is considered low due to established FDA pathways for similar products.

Therapeutic areas: DermatologyEndocrinology
Modalities: Scaffold dressingProtein-based biomaterial (Soy protein)Device (handheld electrospinner for delivery)
Industry: Implantable Medical Devices

Partnerships

Temple University (exclusive licensee of patent portfolio)

Beyond the preview

Go deeper on NeuEsse.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NeuEsse.

Explore the full profile